64595 |
Yesterdays PR was terrific. Brilacidin was found (15) |
farrell |
05/20/2020 8:55:40 PM |
70679 |
IPIX .. NR (non retail) would normally be showing (16) |
4kids |
10/28/2021 12:32:05 PM |
72046 |
Innovation Pharmaceuticals Announces Publication (7) |
Mo |
10/04/2022 12:13:17 PM |
72181 |
WAKEFIELD, MA / January 4, 2023 BT (7) |
Drano |
01/09/2023 8:51:41 AM |
40737 |
Alan, we are living in an Information Age now so |
sox0407 |
01/03/2018 7:12:23 PM |
40736 |
Here's my favorite part of the PR. "The CSR is (7) |
sox0407 |
01/03/2018 7:05:12 PM |
40735 |
And right down near the end of the article, they (1) |
Drano |
01/03/2018 6:23:06 PM |
40734 |
"Immunotherapy can cause perplexing side effects" (1) |
Drano |
01/03/2018 6:17:39 PM |
40733 |
Alan - what do you mean by shares in certificate |
Mabuhay |
01/03/2018 6:11:21 PM |
40732 |
LOL (1) |
Drano |
01/03/2018 5:59:15 PM |
40731 |
Thank you and GL to you as well. I'm just in a |
Mabuhay |
01/03/2018 5:56:58 PM |
40730 |
Double- it all comes down to " I think 1+2+3 = |
Mabuhay |
01/03/2018 5:52:39 PM |
40729 |
We already knew that the idiots' parade of (2) |
Drano |
01/03/2018 5:17:06 PM |
40728 |
Well put, DoubleJ. Very excited about the results |
Phteven C |
01/03/2018 4:52:30 PM |
40727 |
I, for one, am liking the delayed onset data very (5) |
doubleJ23 |
01/03/2018 4:47:14 PM |
40726 |
Looking forward to 'laughing all the way' after (2) |
incubus |
01/03/2018 4:27:39 PM |
40725 |
Almost 507k shares. Time for the liars to claim (2) |
Drano |
01/03/2018 4:02:30 PM |
40724 |
Buying pressure at .74. Volume 427,778 with half (1) |
Drano |
01/03/2018 3:36:47 PM |
40723 |
Good for you having all your shares in |
AlanC |
01/03/2018 3:18:00 PM |
40722 |
Remember that the 60% placebo group getting (3) |
Drano |
01/03/2018 3:01:32 PM |
40721 |
Will be interesting to see if the first (3) |
Darwinian |
01/03/2018 2:46:06 PM |
40720 |
That there is funny! |
daydreaming2 |
01/03/2018 2:22:02 PM |
40719 |
It is exactly how I read the PR and almost the (2) |
daydreaming2 |
01/03/2018 2:20:51 PM |
40718 |
I've been adding every month, including this (3) |
sox0407 |
01/03/2018 2:16:11 PM |
40717 |
Got this back from Leo when I asked him about the (4) |
Georges |
01/03/2018 2:11:41 PM |
40716 |
Email from Leo on why the duration analysis was (5) |
sox0407 |
01/03/2018 2:09:06 PM |
40715 |
"The time needed to write the CSR generally (2) |
sox0407 |
01/03/2018 2:03:58 PM |
40714 |
Detailed comparison of B-OM to competition. I am (7) |
Mo |
01/03/2018 1:38:35 PM |
40713 |
That would be a welcomed relief. Getting tired of (2) |
scgmck1 |
01/03/2018 1:29:41 PM |
40712 |
Nice summary from BioHedge at other board: I (3) |
Mo |
01/03/2018 1:23:28 PM |
40711 |
Good stuff. Many people don't realize how many (3) |
someconcerns |
01/03/2018 12:17:59 PM |
40710 |
Nice to see the cost of markers rising. Real (2) |
AlanC |
01/03/2018 11:55:19 AM |
40709 |
http://www.dailymail.co.uk/news/cancer/index.html |
rosalieone |
01/03/2018 11:51:07 AM |
40708 |
Great news out of HQ this morning. Incidence of (5) |
scgmck1 |
01/03/2018 11:44:47 AM |
40707 |
I read iHub daily , I don t waste time respond to (5) |
Georges |
01/03/2018 11:31:15 AM |
40706 |
So far looks like buying pressure. 45 minutes |
Drano |
01/03/2018 10:15:42 AM |
40705 |
I took your 'ignore' advice and the posts I see (4) |
petemantx |
01/03/2018 10:07:48 AM |
40704 |
The news today is very impressive. Just looking (2) |
Drano |
01/03/2018 9:54:33 AM |
40703 |
All 3 IPIX drugs have MULTIPLE uses. Kind of a (4) |
NotRichYet2 |
01/03/2018 9:53:18 AM |
40702 |
We are understanding of Ratshitsmith. We (1) |
Kelt |
01/03/2018 9:48:16 AM |
40701 |
Oooh. I take it back, I thought the PDF was just (1) |
Phteven C |
01/03/2018 9:47:16 AM |
40700 |
I think the Corporate Overview, put out yesterday (3) |
petemantx |
01/03/2018 9:45:40 AM |
40699 |
Schizophrenia is a bitch....we should be more (4) |
B.Izzy |
01/03/2018 9:39:15 AM |
40698 |
Interesting line up out of the gate this morning. |
AlanC |
01/03/2018 9:39:01 AM |
40697 |
I agree with you that the update will likely be a (3) |
AlanC |
01/03/2018 9:34:16 AM |
40696 |
Today's PR show us how the company is going to be (2) |
Drano |
01/03/2018 9:29:59 AM |
40695 |
The multi-identity has admitted to multiple (7) |
Drano |
01/03/2018 9:24:01 AM |
40694 |
Innovation Pharmaceuticals Brilacidin Meets Key (3) |
AlanC |
01/03/2018 8:40:41 AM |
40693 |
They gave the average duration reduction on the (1) |
Phteven C |
01/03/2018 8:13:56 AM |
40692 |
YUP - Another milestone successfully MEET. It (1) |
NotRichYet2 |
01/03/2018 8:07:28 AM |
40691 |
That's not true at all. Anyone can see the (1) |
Phteven C |
01/03/2018 8:03:51 AM |
40690 |
Results were so good there wasn't enough patients |
daydreaming2 |
01/03/2018 7:15:08 AM |
40689 |
PR - And the news continues and continues to be (2) |
daydreaming2 |
01/03/2018 7:11:29 AM |
40688 |
Mabuhay, congrats with your purchase. Amazing buy (1) |
Drunko |
01/03/2018 6:25:34 AM |